At the 2025 MedTech conference in San Diego, experts noted a decline in MedTech M&A deals and venture financing rounds. GlobalData analysis shows a downward trend in deals for major MedTech companies. Despite fewer deals, the average size of M&A deals has increased, with a focus on acquiring advanced, innovative companies. Top MedTech companies are investing strategically in companies with growth potential. Some are divesting non-core divisions to focus on high-growth markets. Medtronic, Becton Dickinson & Co, and Johnson & Johnson are spinning off or divesting divisions to streamline their portfolios. Overall, MedTech companies are focusing on innovation and growth.

Read more at Yahoo Finance: Declining deals, rising values, and early-stage investment focus